Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;9(4):219-36.
doi: 10.1016/j.jamda.2008.01.003.

The Cytokine Basis of Cachexia and Its Treatment: Are They Ready for Prime Time?


The Cytokine Basis of Cachexia and Its Treatment: Are They Ready for Prime Time?

Shing-Shing Yeh et al. J Am Med Dir Assoc. .


Cachexia is a hypercatabolic condition that is often associated with the terminal stages of many diseases, in which the patient's resting metabolic rate is high and loss of muscle and fat tissue mass occur at an alarming rate. The patient also usually has concurrent anorexia, amplifying the wasting syndrome that is cachexia. The greater the extent of cachexia (regardless of underlying disease), the worse the prognosis. Efforts to treat cachexia over the years have fallen short of satisfactorily reversing the wasting syndrome. This article reviews the pathophysiology of cachexia, enumerating the different pro-inflammatory cytokines that contribute to the syndrome and attempting to illustrate their interwoven pathways. We also review the different treatments that have been explored, as well as the recent literature addressing the use of anti-cytokine therapy to treat cachexia.

Similar articles

See all similar articles

Cited by 9 articles

  • Anorexia of Aging: Risk Factors, Consequences, and Potential Treatments.
    Landi F, Calvani R, Tosato M, Martone AM, Ortolani E, Savera G, Sisto A, Marzetti E. Landi F, et al. Nutrients. 2016 Jan 27;8(2):69. doi: 10.3390/nu8020069. Nutrients. 2016. PMID: 26828516 Free PMC article. Review.
  • Anorexia of aging: a true geriatric syndrome.
    Morley JE. Morley JE. J Nutr Health Aging. 2012 May;16(5):422-5. doi: 10.1007/s12603-012-0061-9. J Nutr Health Aging. 2012. PMID: 22555783 No abstract available.
  • The effect of rosuvastatin in a murine model of influenza A infection.
    Radigan KA, Urich D, Misharin AV, Chiarella SE, Soberanes S, Gonzalez A, Perlman H, Wunderink RG, Budinger GR, Mutlu GM. Radigan KA, et al. PLoS One. 2012;7(4):e35788. doi: 10.1371/journal.pone.0035788. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22536437 Free PMC article.
  • Sarcopenia with limited mobility: an international consensus.
    Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, Cederholm T, Coats AJ, Cummings SR, Evans WJ, Fearon K, Ferrucci L, Fielding RA, Guralnik JM, Harris TB, Inui A, Kalantar-Zadeh K, Kirwan BA, Mantovani G, Muscaritoli M, Newman AB, Rossi-Fanelli F, Rosano GM, Roubenoff R, Schambelan M, Sokol GH, Storer TW, Vellas B, von Haehling S, Yeh SS, Anker SD; Society on Sarcopenia, Cachexia and Wasting Disorders Trialist Workshop. Morley JE, et al. J Am Med Dir Assoc. 2011 Jul;12(6):403-9. doi: 10.1016/j.jamda.2011.04.014. J Am Med Dir Assoc. 2011. PMID: 21640657 Free PMC article.
  • Laboratory aspects relating to the detection and prevention of frailty.
    Heppner HJ, Bauer JM, Sieber CC, Bertsch T. Heppner HJ, et al. Int J Prev Med. 2010 Summer;1(3):149-57. Int J Prev Med. 2010. PMID: 21566784 Free PMC article.
See all "Cited by" articles

MeSH terms

LinkOut - more resources